Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy

Ferla, V; Antonini, E; Perini, T; Farina, F; Masottini, S; Malato, S; Marktel, S; Stanghellini, MTL; Tresoldi, C; Ciceri, F; Marcatti, M

Ferla, V (通讯作者),Ist Sci San Raffaele, Hematol & Bone Marrow Transplantat, Milan, Italy.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

Assessment of minimal residual disease (MRD) is becoming a standard diagnostic tool for curable hematological malignancies such as chronic and acute m......

Full Text Link